Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. No user-facing content or study details appear to be affected.
    Difference
    0.0%
    Check dated 2026-03-06T17:52:08.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Minor site-wide footer and label edits include the addition of a revision note (Revision: v3.4.2) and the removal of Bayer-related links/labels such as 'Click here to find results for studies related to Bayer products', 'Bayer', and 'Helpful Links Provided by'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:48:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Minor revision from v3.4.0 to v3.4.1; no substantive changes to the study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:15:04.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    These changes are minor UI/text updates, including glossary toggle labels (Show glossary / Hide glossary) and footer/versioning text (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-22T17:45:00.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears on the page, replacing the previous Revision: v3.3.3. This is a metadata version update and does not alter study details, results, or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-01-15T10:51:01.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Locations section updated with a revised global list of study sites across multiple regions (e.g., U.S. states, Australia, Canada, Europe, and others). This corresponds to Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-17T21:49:28.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.